$301 Million is the total value of Defender Capital, LLC.'s 40 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DHR | Buy | DANAHER CORP | $42,276,000 | +19.6% | 157,538 | +0.7% | 14.05% | +11.4% |
| FTV | Buy | FORTIVE CORPORATION | $27,267,000 | +31.3% | 391,001 | +33.1% | 9.06% | +22.3% |
| AXON | Buy | AXON ENTERPRISE INC | $17,493,000 | +39.3% | 98,950 | +12.9% | 5.81% | +29.8% |
| LCTX | Buy | LINEAGE CELL THERAPEUTIC | $14,354,000 | +23.5% | 5,036,720 | +1.7% | 4.77% | +15.1% |
| CFX | Buy | COLFAX CORPORATION | $10,732,000 | +76.5% | 234,291 | +68.8% | 3.57% | +64.4% |
| OCX | Buy | ONCOCYTE CORP | $7,732,000 | +147.7% | 1,347,200 | +122.9% | 2.57% | +130.6% |
| CGEN | Buy | COMPUGEN LIMITEDord | $2,063,000 | +2.4% | 244,872 | +4.7% | 0.68% | -4.6% |
| AMWL | Buy | AMERICAN WELL CORPcl a | $1,833,000 | -21.9% | 145,775 | +8.1% | 0.61% | -27.2% |
| KMI | Buy | KINDER MORGAN INC | $1,276,000 | +410.4% | 70,000 | +366.7% | 0.42% | +376.4% |
| INO | Buy | INOVIO PHARMA | $1,255,000 | +3.7% | 135,466 | +3.8% | 0.42% | -3.5% |
| INTC | New | INTEL CORPORATION | $1,222,000 | – | 20,000 | +100.0% | 0.41% | – |
| ITEQ | Buy | BLUESTAR ISRAEL TECHNOLOGYetf | $812,000 | +13.2% | 11,607 | +5.2% | 0.27% | +5.5% |
| MSFT | Buy | MICROSOFT CORP | $555,000 | +52.5% | 2,050 | +32.9% | 0.18% | +41.5% |
| IVV | Buy | IVVetf | $506,000 | +8.1% | 1,179 | +0.3% | 0.17% | +0.6% |
| LNDC | Buy | LANDEC CORP | $450,000 | +41.5% | 40,000 | +33.3% | 0.15% | +32.7% |
| PFE | New | PFIZER INC | $399,000 | – | 10,200 | +100.0% | 0.13% | – |
| PLTR | New | PALANTIR TECHNOLOGIES | $395,000 | – | 15,000 | +100.0% | 0.13% | – |
| MLM | New | MARTIN MARIETTA MATR | $334,000 | – | 950 | +100.0% | 0.11% | – |
| BE | New | BLOOM ENERGY | $322,000 | – | 12,000 | +100.0% | 0.11% | – |
| ARWR | New | ARROWHEAD PHARMACUTICALS | $248,000 | – | 3,000 | +100.0% | 0.08% | – |
| STCN | Buy | STEEL CONNECT INC | $150,000 | +32.7% | 75,000 | +31.6% | 0.05% | +25.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-07-29
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL CL B | 20 | Q3 2023 | 24.4% |
| DANAHER CORPORATION COM | 20 | Q3 2023 | 18.3% |
| STAAR SURGICAL CORPORATION | 20 | Q3 2023 | 20.2% |
| FORTIVE CORPORATION | 20 | Q3 2023 | 14.3% |
| MONSTER BEVERAGE CORPORATION | 20 | Q3 2023 | 17.3% |
| APPLE INC | 20 | Q3 2023 | 0.6% |
| AMAZON INC COM | 20 | Q3 2023 | 0.4% |
| VANGUARD SHORT TERM TREASURY ETF IV | 17 | Q3 2023 | 23.9% |
| LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 4.8% |
| COMPUGEN LTD ORD | 17 | Q1 2023 | 1.9% |
View Defender Capital, LLC.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-06 |
| 13F-HR | 2024-01-23 |
| 13F-HR | 2023-10-23 |
| 13F-HR | 2023-07-18 |
| 13F-HR/A | 2023-05-16 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-12 |
| 13F-HR | 2022-10-18 |
| 13F-HR | 2022-07-26 |
| 13F-HR/A | 2022-06-07 |
View Defender Capital, LLC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.